4//SEC Filing
OMNI BIO PHARMACEUTICAL, INC. 4
Accession 0001181431-13-015497
CIK 0001389870operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 9:06 PM ET
Size
9.2 KB
Accession
0001181431-13-015497
Insider Transaction Report
Form 4
BATHGATE STEVEN MARK
Director
Transactions
- Sale
Common Stock
2013-03-06$0.25/sh−300,000$75,000→ 417,750 total(indirect: By LLC)
Holdings
- 202,355
Common Stock
- 100,000(indirect: By LLC)
Common Stock
- 30,000(indirect: By Partnership)
Common Stock
- 604,000(indirect: By Spouse)
Common Stock
- 50,000(indirect: By daughter)
Common Stock
Footnotes (3)
- [F1]The reporting person is a Senior Managing Partner of GVC Partners LLC. GVC Partners LLC is the sole member of GVC Capital LLC.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of such securities for purposes of Section 16 or for any other purpose.
- [F3]On March 6, 2013, GVC Partners LLC sold 100,000 shares of the issuer's common stock to GVC Capital LLC and 100,000 shares of the issuer's common stock to the reporting person. These transaction are treated soley as a change in the form of beneficial ownership of the reporting person.
Documents
Issuer
OMNI BIO PHARMACEUTICAL, INC.
CIK 0001389870
Entity typeoperating
IncorporatedCO
Related Parties
1- filerCIK 0001389870
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 9:06 PM ET
- Size
- 9.2 KB